MAP Kinase-Mutant Hematologic Malignancies and Their Therapeutic Resistance

Request Access

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.

Donavan T. Cheng, Talia Mitchell, A. Zehir, et al.. (2015). The Journal of molecular diagnostics : JMD. Cited 1,871 times. https://doi.org/10.1016/j.jmoldx.2014.12.006

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

D. Hyman, I. Puzanov, V. Subbiah, et al.. (2015). The New England journal of medicine. Cited 1,589 times. https://doi.org/10.1056/NEJMoa1502309

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia

Jinghui Zhang, L. Ding, Linda Holmfeldt, et al.. (2012). Nature. Cited 1,570 times. https://doi.org/10.1038/nature10725

Recurrent BRAF mutations in Langerhans cell histiocytosis.

G. Badalian‐Very, J. Vergilio, B. Degar, et al.. (2010). Blood. Cited 1,138 times. https://doi.org/10.1182/blood-2010-04-279083

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

E. Diamond, B. Durham, J. Haroche, et al.. (2016). Cancer discovery. Cited 432 times. https://doi.org/10.1158/2159-8290.CD-15-0913

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.

Rikhia Chakraborty, O. Hampton, Xiaoyun Shen, et al.. (2014). Blood. Cited 388 times. https://doi.org/10.1182/blood-2014-05-577825

High Yield of RNA Sequencing for Targetable Kinase Fusions in Lung Adenocarcinomas with No Mitogenic Driver Alteration Detected by DNA Sequencing and Low Tumor Mutation Burden

R. Benayed, M. Offin, Kerry A Mullaney, et al.. (2019). Clinical Cancer Research. Cited 371 times. https://doi.org/10.1158/1078-0432.CCR-19-0225

Efficacy of MEK Inhibition in Patients with Histiocytic Neoplasms

E. Diamond, B. Durham, G. Ulaner, et al.. (2019). Nature. Cited 320 times. https://doi.org/10.1038/s41586-019-1012-y

An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia.

T. Gruber, Amanda Larson Gedman, Jinghui Zhang, et al.. (2012). Cancer cell. Cited 273 times. https://doi.org/10.1016/j.ccr.2012.10.007

Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects.

Xu-ming Dai, Gregory R. Ryan, A. Hapel, et al.. (2002). Blood. Cited 271 times.

A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease

E. Mass, C. Jacome-Galarza, T. Blank, et al.. (2017). Nature. Cited 181 times. https://doi.org/10.1038/nature23672

Familial clustering of Langerhans cell histiocytosis

M. Aricò, K. Nichols, J. Whitlock, et al.. (1999). British Journal of Haematology. Cited 121 times. https://doi.org/10.1046/j.1365-2141.1999.01777.x

Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells.

B. Durham, Damien Roos-Weil, C. Baillou, et al.. (2017). Blood. Cited 118 times. https://doi.org/10.1182/blood-2016-12-757377

Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations.

B. Durham, B. Getta, S. Dietrich, et al.. (2017). Blood. Cited 105 times. https://doi.org/10.1182/blood-2017-01-765107

Extracellular assembly and activation principles of oncogenic class III receptor tyrosine kinases

K. Verstraete, S. Savvides. (2012). Nature Reviews Cancer. Cited 86 times. https://doi.org/10.1038/nrc3371

Human IL-34 and CSF-1 establish structurally similar extracellular assemblies with their common hematopoietic receptor.

J. Felix, J. Elegheert, I. Gutsche, et al.. (2013). Structure. Cited 73 times. https://doi.org/10.1016/j.str.2013.01.018

The 2.7 A crystal structure of the autoinhibited human c-Fms kinase domain.

M. Walter, I. Lucet, O. Patel, et al.. (2007). Journal of molecular biology. Cited 70 times. https://doi.org/10.1016/J.JMB.2007.01.036

Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1

J. Elegheert, N. Bracke, P. Pouliot, et al.. (2012). Nature Structural &Molecular Biology. Cited 49 times. https://doi.org/10.1038/nsmb.2367

Extracellular complexes of the hematopoietic human and mouse CSF-1 receptor are driven by common assembly principles.

J. Elegheert, A. Desfosses, A. Shkumatov, et al.. (2011). Structure. Cited 45 times. https://doi.org/10.1016/j.str.2011.10.012

Structure and Assembly Mechanism of the Signaling Complex Mediated by Human CSF-1.

J. Felix, Steven De Munck, K. Verstraete, et al.. (2015). Structure. Cited 39 times. https://doi.org/10.1016/j.str.2015.06.019
NCPI Dataset Catalog
Feedback & Support
v0.9.0-d9e5747